Template:Pyelonephritis antibiotics - Revision history

Danbot: Add pediatric outpatient dosing section with oral cephalosporins and TMP/SMX

2026-03-20T12:55:47Z

Add pediatric outpatient dosing section with oral cephalosporins and TMP/SMX

← Revisión anterior		Revisión del 12:55 20 mar 2026
Línea 17:		Línea 17:
	*{{AntibioticDose\|disease=Pyelonephritis\|drug=Cefepime\|dose=2gm IV q8hr\|context=Adult Inpatient}} '''OR'''		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Cefepime\|dose=2gm IV q8hr\|context=Adult Inpatient}} '''OR'''
	*{{AntibioticDose\|disease=Pyelonephritis\|drug=Imipenem/Cilastatin\|dose=500mg IV q8hr\|context=Adult Inpatient}}		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Imipenem/Cilastatin\|dose=500mg IV q8hr\|context=Adult Inpatient}}


			====Pediatric Outpatient Options====
			*{{AntibioticDose\|disease=Pyelonephritis\|drug=Cephalexin\|dose=25-50mg/kg/day PO divided q6-8h x 10-14 days (max 500mg/dose)\|context=Pediatric Outpatient\|population=Pediatric}} '''OR'''
			*{{AntibioticDose\|disease=Pyelonephritis\|drug=Cefixime\|dose=8mg/kg PO daily x 10-14 days (max 400mg)\|context=Pediatric Outpatient\|population=Pediatric}} '''OR'''
			*{{AntibioticDose\|disease=Pyelonephritis\|drug=Cefdinir\|dose=14mg/kg/day PO divided BID x 10 days (max 600mg/day)\|context=Pediatric Outpatient\|population=Pediatric}} '''OR'''
			*{{AntibioticDose\|disease=Pyelonephritis\|drug=Cefpodoxime\|dose=10mg/kg/day PO divided BID x 10 days (max 200mg/dose)\|context=Pediatric Outpatient\|population=Pediatric}} '''OR'''
			*{{AntibioticDose\|disease=Pyelonephritis\|drug=Trimethoprim-Sulfamethoxazole DS\|display=TMP/SMX\|dose=6-12mg/kg/day (TMP) PO divided BID x 10-14 days\|context=Pediatric Outpatient\|population=Pediatric}}
	====Pediatric Inpatient Options====		====Pediatric Inpatient Options====
	*{{AntibioticDose\|disease=Pyelonephritis\|drug=Ceftriaxone\|dose=75mg/kg IV QD\|context=Pediatric Inpatient\|population=Pediatric}} '''OR'''		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Ceftriaxone\|dose=75mg/kg IV QD\|context=Pediatric Inpatient\|population=Pediatric}} '''OR'''

Danbot: Add AntibioticDose entries: Ampicillin/Sulbactam

2026-03-20T10:54:32Z

Add AntibioticDose entries: Ampicillin/Sulbactam

← Revisión anterior		Revisión del 10:54 20 mar 2026
Línea 21:		Línea 21:
	*{{AntibioticDose\|disease=Pyelonephritis\|drug=Cefotaxime\|dose=50mg/kg IV q8hrs\|context=Pediatric Inpatient\|population=Pediatric}} '''OR'''		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Cefotaxime\|dose=50mg/kg IV q8hrs\|context=Pediatric Inpatient\|population=Pediatric}} '''OR'''
	*{{AntibioticDose\|disease=Pyelonephritis\|drug=Ampicillin\|dose=25mg/kg IV q6hrs\|context=Pediatric Inpatient\|population=Pediatric}} '''+''' {{AntibioticDose\|disease=Pyelonephritis\|drug=Gentamicin\|dose=2.5mg/kg IV q8hrs\|context=Pediatric Inpatient\|population=Pediatric\|link=no}}		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Ampicillin\|dose=25mg/kg IV q6hrs\|context=Pediatric Inpatient\|population=Pediatric}} '''+''' {{AntibioticDose\|disease=Pyelonephritis\|drug=Gentamicin\|dose=2.5mg/kg IV q8hrs\|context=Pediatric Inpatient\|population=Pediatric\|link=no}}
			*{{AntibioticDose\|drug=Ampicillin/Sulbactam\|dose=3g IM/IV q6 hours x 14 days\|context=UTI, Pyelonephritis\|disease=Pyelonephritis\|population=Adult}}

Danbot: Convert to AntibioticDose with disease=Pyelonephritis, includes Adult + Pediatric. Fixed Gentamycin→Gentamicin

2026-03-19T23:39:48Z

Convert to AntibioticDose with disease=Pyelonephritis, includes Adult + Pediatric. Fixed Gentamycin→Gentamicin

← Revisión anterior		Revisión del 23:39 19 mar 2026
Línea 1:		Línea 1:
	''Treatment is targeted at [[E. coli]], [[Enterococcus]], [[Klebsiella]], [[Proteus mirabilis]], [[S. saprophyticus]].''		''Treatment is targeted at [[E. coli]], [[Enterococcus]], [[Klebsiella]], [[Proteus mirabilis]], [[S. saprophyticus]].''
	====Outpatient====		====Outpatient====
	''Consider one dose of [[Ceftriaxone]] 1g IV or [[~~Gentamycin~~]] 7mg/kg IV if the regional susceptibility of [[TMP/SMX]] or [[Fluoroquinolones]] is <80%''		''Consider one dose of [[Ceftriaxone]] 1g IV or [[Gentamicin]] 7mg/kg IV if the regional susceptibility of [[TMP/SMX]] or [[Fluoroquinolones]] is <80%''
	*[[Ciprofloxacin]] 500mg PO BID x7 days '''OR'''		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Ciprofloxacin\|dose=500mg PO BID x7 days\|context=Outpatient}} '''OR'''
	*[[Trimethoprim-Sulfamethoxazole DS]] 160/800mg PO BID x14 days '''OR'''<ref>Gupta K, Hooton TM, Naber KG, et al. International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women. Clinical Infectious Diseases. 2011;52(5):e103-e120. doi:10.1093/cid/ciq257</ref>		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Trimethoprim-Sulfamethoxazole DS\|dose=160/800mg PO BID x14 days\|context=Outpatient}} '''OR'''<ref>Gupta K, Hooton TM, Naber KG, et al. International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women. Clinical Infectious Diseases. 2011;52(5):e103-e120. doi:10.1093/cid/ciq257</ref>
	*[[Cephalexin]] 500mg QID PO x 10-14 days (OR consider 1000mg BID ~~if difficulty with QID regimen~~) '''OR'''		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Cephalexin\|dose=500mg QID PO x 10-14 days (OR consider 1000mg BID)\|context=Outpatient}} '''OR'''
	*[[Cefdinir]] 300mg BID PO x 10-14 days '''OR'''		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Cefdinir\|dose=300mg BID PO x 10-14 days\|context=Outpatient}} '''OR'''
	*[[Cefpodoxime]] 200mg PO BID x 10 days '''OR'''<ref>Colgan R, Williams M. Diagnosis and treatment of acute uncomplicated cystitis. Am Fam Physician. 2011 Oct 1;84(7):771-6.</ref>		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Cefpodoxime\|dose=200mg PO BID x 10 days\|context=Outpatient}} '''OR'''<ref>Colgan R, Williams M. Diagnosis and treatment of acute uncomplicated cystitis. Am Fam Physician. 2011 Oct 1;84(7):771-6.</ref>
	*[[Cefixime]] 400mg PO daily x 10 days '''OR'''<ref>Acute Pyelonephritis in Adults. Johnson, JR and Russo, TA. New England Journal of Medicine 2018; 378:48-59.</ref>		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Cefixime\|dose=400mg PO daily x 10 days\|context=Outpatient}} '''OR'''<ref>Acute Pyelonephritis in Adults. Johnson, JR and Russo, TA. New England Journal of Medicine 2018; 378:48-59.</ref>
	*[[Levofloxacin]] 750mg PO QD x7 days<ref>Sandberg T. et al. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Lancet. 2012 Aug 4;380(9840):484-90.</ref>		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Levofloxacin\|dose=750mg PO QD x7 days\|context=Outpatient}}<ref>Sandberg T. et al. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Lancet. 2012 Aug 4;380(9840):484-90.</ref>

	====Adult Inpatient Options====		====Adult Inpatient Options====
	*[[Ciprofloxacin]] 400mg IV q12hr '''OR'''		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Ciprofloxacin\|dose=400mg IV q12hr\|context=Adult Inpatient}} '''OR'''
	*[[Ceftriaxone]] 1gm IV QD <span style="color:red">'''(Preferred in pregnancy)'''</span> '''OR'''		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Ceftriaxone\|dose=1gm IV QD\|context=Adult Inpatient}} <span style="color:red">'''(Preferred in pregnancy)'''</span> '''OR'''
	*Cefotaxime 1-2gm IV q8hr '''OR'''		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Cefotaxime\|dose=1-2gm IV q8hr\|context=Adult Inpatient}} '''OR'''
	*[[Gentamicin]] 3mg/kg/day divided q8hr +/- [[ampicillin]] 1–2 gm q4hr '''OR'''		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Gentamicin\|dose=3mg/kg/day divided q8hr\|context=Adult Inpatient}} +/- [[ampicillin]] 1–2 gm q4hr '''OR'''
	*[[Piperacillin/Tazobactam]] 3.375 gm IV q6hr '''OR'''		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Piperacillin/Tazobactam\|dose=3.375 gm IV q6hr\|context=Adult Inpatient}} '''OR'''
	*[[Cefepime]] 2gm IV q8hr '''OR'''		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Cefepime\|dose=2gm IV q8hr\|context=Adult Inpatient}} '''OR'''
	*[[Imipenem]] 500mg IV q8hr		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Imipenem/Cilastatin\|dose=500mg IV q8hr\|context=Adult Inpatient}}

	====Pediatric Inpatient Options====		====Pediatric Inpatient Options====
	*[[Ceftriaxone]] 75mg/kg IV QD '''OR'''		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Ceftriaxone\|dose=75mg/kg IV QD\|context=Pediatric Inpatient\|population=Pediatric}} '''OR'''
	*[[Cefotaxime]] 50mg/kg IV q8hrs '''OR'''		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Cefotaxime\|dose=50mg/kg IV q8hrs\|context=Pediatric Inpatient\|population=Pediatric}} '''OR'''
	*[[Ampicillin]] 25mg/kg IV q6hrs '''+''' [[Gentamicin]] 2.5mg/kg IV q8hrs		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Ampicillin\|dose=25mg/kg IV q6hrs\|context=Pediatric Inpatient\|population=Pediatric}} '''+''' {{AntibioticDose\|disease=Pyelonephritis\|drug=Gentamicin\|dose=2.5mg/kg IV q8hrs\|context=Pediatric Inpatient\|population=Pediatric\|link=no}}

Rossdonaldson1 at 22:37, 21 September 2022

2022-09-21T22:37:22Z

← Revisión anterior		Revisión del 22:37 21 sep 2022
Línea 1:		Línea 1:
	''Treatment is targeted at [[E. coli]], [[Enterococcus]], [[Klebsiella]], [[Proteus mirabilis]], [[S. saprophyticus]]''		''Treatment is targeted at [[E. coli]], [[Enterococcus]], [[Klebsiella]], [[Proteus mirabilis]], [[S. saprophyticus]].''
	====Outpatient====		====Outpatient====
	''Consider one dose of [[Ceftriaxone]] 1g IV or [[Gentamycin]] 7mg/kg IV if the regional susceptibility of [[TMP/SMX]] or [[Fluoroquinolones]] is <80%''		''Consider one dose of [[Ceftriaxone]] 1g IV or [[Gentamycin]] 7mg/kg IV if the regional susceptibility of [[TMP/SMX]] or [[Fluoroquinolones]] is <80%''

Corkeith: /* Adult Inpatient Options */

2021-11-16T04:57:06Z

Adult Inpatient Options

← Revisión anterior		Revisión del 04:57 16 nov 2021
Línea 12:		Línea 12:
	====Adult Inpatient Options====		====Adult Inpatient Options====
	*[[Ciprofloxacin]] 400mg IV q12hr '''OR'''		*[[Ciprofloxacin]] 400mg IV q12hr '''OR'''
	*[[Ceftriaxone]] 1gm IV QD '''OR'''		*[[Ceftriaxone]] 1gm IV QD <span style="color:red">'''(Preferred in pregnancy)'''</span> '''OR'''
	*Cefotaxime 1-2gm IV q8hr '''OR'''		*Cefotaxime 1-2gm IV q8hr '''OR'''
	*[[Gentamicin]] 3mg/kg/day divided q8hr +/- [[ampicillin]] 1–2 gm q4hr '''OR'''		*[[Gentamicin]] 3mg/kg/day divided q8hr +/- [[ampicillin]] 1–2 gm q4hr '''OR'''

ElavemanMD: /* Outpatient */

2019-07-20T17:55:01Z

Outpatient

← Revisión anterior		Revisión del 17:55 20 jul 2019
Línea 3:		Línea 3:
	''Consider one dose of [[Ceftriaxone]] 1g IV or [[Gentamycin]] 7mg/kg IV if the regional susceptibility of [[TMP/SMX]] or [[Fluoroquinolones]] is <80%''		''Consider one dose of [[Ceftriaxone]] 1g IV or [[Gentamycin]] 7mg/kg IV if the regional susceptibility of [[TMP/SMX]] or [[Fluoroquinolones]] is <80%''
	*[[Ciprofloxacin]] 500mg PO BID x7 days '''OR'''		*[[Ciprofloxacin]] 500mg PO BID x7 days '''OR'''
			*[[Trimethoprim-Sulfamethoxazole DS]] 160/800mg PO BID x14 days '''OR'''<ref>Gupta K, Hooton TM, Naber KG, et al. International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women. Clinical Infectious Diseases. 2011;52(5):e103-e120. doi:10.1093/cid/ciq257</ref>
			*[[Cephalexin]] 500mg QID PO x 10-14 days (OR consider 1000mg BID if difficulty with QID regimen) '''OR'''
			*[[Cefdinir]] 300mg BID PO x 10-14 days '''OR'''
	*[[Cefpodoxime]] 200mg PO BID x 10 days '''OR'''<ref>Colgan R, Williams M. Diagnosis and treatment of acute uncomplicated cystitis. Am Fam Physician. 2011 Oct 1;84(7):771-6.</ref>		*[[Cefpodoxime]] 200mg PO BID x 10 days '''OR'''<ref>Colgan R, Williams M. Diagnosis and treatment of acute uncomplicated cystitis. Am Fam Physician. 2011 Oct 1;84(7):771-6.</ref>
	*[[Cefixime]] 400mg PO daily x 10 days '''OR'''<ref>Acute Pyelonephritis in Adults. Johnson, JR and Russo, TA. New England Journal of Medicine 2018; 378:48-59.</ref>		*[[Cefixime]] 400mg PO daily x 10 days '''OR'''<ref>Acute Pyelonephritis in Adults. Johnson, JR and Russo, TA. New England Journal of Medicine 2018; 378:48-59.</ref>

Bchap23: /* Outpatient */

2018-08-31T17:23:05Z

Outpatient

← Revisión anterior		Revisión del 17:23 31 ago 2018
Línea 3:		Línea 3:
	''Consider one dose of [[Ceftriaxone]] 1g IV or [[Gentamycin]] 7mg/kg IV if the regional susceptibility of [[TMP/SMX]] or [[Fluoroquinolones]] is <80%''		''Consider one dose of [[Ceftriaxone]] 1g IV or [[Gentamycin]] 7mg/kg IV if the regional susceptibility of [[TMP/SMX]] or [[Fluoroquinolones]] is <80%''
	*[[Ciprofloxacin]] 500mg PO BID x7 days '''OR'''		*[[Ciprofloxacin]] 500mg PO BID x7 days '''OR'''
	*[[Cefpodoxime]] 200mg PO BID ~~x10-14~~ days '''OR'''<ref>Colgan R, Williams M. Diagnosis and treatment of acute uncomplicated cystitis. Am Fam Physician. 2011 Oct 1;84(7):771-6.</ref>		*[[Cefpodoxime]] 200mg PO BID x 10 days '''OR'''<ref>Colgan R, Williams M. Diagnosis and treatment of acute uncomplicated cystitis. Am Fam Physician. 2011 Oct 1;84(7):771-6.</ref>
			*[[Cefixime]] 400mg PO daily x 10 days '''OR'''<ref>Acute Pyelonephritis in Adults. Johnson, JR and Russo, TA. New England Journal of Medicine 2018; 378:48-59.</ref>
	*[[Levofloxacin]] 750mg PO QD x7 days<ref>Sandberg T. et al. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Lancet. 2012 Aug 4;380(9840):484-90.</ref>		*[[Levofloxacin]] 750mg PO QD x7 days<ref>Sandberg T. et al. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Lancet. 2012 Aug 4;380(9840):484-90.</ref>

Mholtz at 20:05, 19 November 2017

2017-11-19T20:05:15Z

← Revisión anterior		Revisión del 20:05 19 nov 2017
Línea 2:		Línea 2:
	====Outpatient====		====Outpatient====
	''Consider one dose of [[Ceftriaxone]] 1g IV or [[Gentamycin]] 7mg/kg IV if the regional susceptibility of [[TMP/SMX]] or [[Fluoroquinolones]] is <80%''		''Consider one dose of [[Ceftriaxone]] 1g IV or [[Gentamycin]] 7mg/kg IV if the regional susceptibility of [[TMP/SMX]] or [[Fluoroquinolones]] is <80%''
	*[[Ciprofloxacin]] 500mg BID ~~x 7~~ days OR		*[[Ciprofloxacin]] 500mg PO BID x7 days '''OR'''
	*[[Cefpodoxime]] ~~200 mg~~ BID x10-14 days OR<ref>Colgan R, Williams M. Diagnosis and treatment of acute uncomplicated cystitis. Am Fam Physician. 2011 Oct 1;84(7):771-6.</ref>		*[[Cefpodoxime]] 200mg PO BID x10-14 days '''OR'''<ref>Colgan R, Williams M. Diagnosis and treatment of acute uncomplicated cystitis. Am Fam Physician. 2011 Oct 1;84(7):771-6.</ref>
	*[[Levofloxacin]] 750mg PO ~~once x 7~~ days<ref>Sandberg T. et al. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Lancet. 2012 Aug 4;380(9840):484-90.</ref>		*[[Levofloxacin]] 750mg PO QD x7 days<ref>Sandberg T. et al. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Lancet. 2012 Aug 4;380(9840):484-90.</ref>

	====Adult Inpatient Options====		====Adult Inpatient Options====
	*[[Ciprofloxacin]] 400mg IV q12hr OR		*[[Ciprofloxacin]] 400mg IV q12hr '''OR'''
	*[[Ceftriaxone]] 1gm IV QD OR		*[[Ceftriaxone]] 1gm IV QD '''OR'''
	*Cefotaxime 1-2gm IV q8hr OR		*Cefotaxime 1-2gm IV q8hr '''OR'''
	*[[Gentamicin]] 3mg/kg/day divided q8hr +/- [[ampicillin]] 1–2 gm q4hr OR		*[[Gentamicin]] 3mg/kg/day divided q8hr +/- [[ampicillin]] 1–2 gm q4hr '''OR'''
	*[[Piperacillin/Tazobactam]] 3.375 gm IV q6hr OR		*[[Piperacillin/Tazobactam]] 3.375 gm IV q6hr '''OR'''
	*[[Cefepime]] 2gm IV q8hr OR		*[[Cefepime]] 2gm IV q8hr '''OR'''
	*[[Imipenem]] 500mg IV q8hr		*[[Imipenem]] 500mg IV q8hr

	====Pediatric Inpatient Options====		====Pediatric Inpatient Options====
	*[[Ceftriaxone]] 75mg/kg IV ~~once daily~~		*[[Ceftriaxone]] 75mg/kg IV QD '''OR'''
	*[[Cefotaxime]] 50mg/kg IV q8hrs		*[[Cefotaxime]] 50mg/kg IV q8hrs '''OR'''
	*[[Ampicillin]] 25mg/kg IV q6hrs + [[Gentamicin]] 2.5mg/kg IV q8hrs		*[[Ampicillin]] 25mg/kg IV q6hrs '''+''' [[Gentamicin]] 2.5mg/kg IV q8hrs

Rossdonaldson1: /* Adult Inpatient Options */

2017-11-19T19:39:40Z

Adult Inpatient Options

← Revisión anterior		Revisión del 19:39 19 nov 2017
Línea 9:		Línea 9:
	*[[Ceftriaxone]] 1gm IV QD OR		*[[Ceftriaxone]] 1gm IV QD OR
	*Cefotaxime 1-2gm IV q8hr OR		*Cefotaxime 1-2gm IV q8hr OR
	*[[Gentamicin]] 3mg/kg/day divided q8hr +/- ampicillin 1–2 gm q4hr OR		*[[Gentamicin]] 3mg/kg/day divided q8hr +/- [[ampicillin]] 1–2 gm q4hr OR
	*[[Piperacillin/Tazobactam]] 3.375 gm IV q6hr OR		*[[Piperacillin/Tazobactam]] 3.375 gm IV q6hr OR
	*[[Cefepime]] 2gm IV q8hr OR		*[[Cefepime]] 2gm IV q8hr OR

Rossdonaldson1 at 12:52, 21 April 2015

2015-04-21T12:52:41Z

← Revisión anterior		Revisión del 12:52 21 abr 2015
Línea 1:		Línea 1:
	''Treatment is targeted at [[E. coli]], [[Enterococcus]], [[Klebsiella]], [[Proteus ~~mirabillis~~]], [[S. saprophyticus]]''		''Treatment is targeted at [[E. coli]], [[Enterococcus]], [[Klebsiella]], [[Proteus mirabilis]], [[S. saprophyticus]]''
	====Outpatient====		====Outpatient====
	''Consider one dose of [[Ceftriaxone]] 1g IV or [[Gentamycin]] 7mg/kg IV if the regional susceptibility of [[TMP/SMX]] or [[Fluoroquinolones]] is <80%''		''Consider one dose of [[Ceftriaxone]] 1g IV or [[Gentamycin]] 7mg/kg IV if the regional susceptibility of [[TMP/SMX]] or [[Fluoroquinolones]] is <80%''

← Revisión anterior		Revisión del 12:55 20 mar 2026
Línea 17:		Línea 17:
	*{{AntibioticDose\|disease=Pyelonephritis\|drug=Cefepime\|dose=2gm IV q8hr\|context=Adult Inpatient}} '''OR'''		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Cefepime\|dose=2gm IV q8hr\|context=Adult Inpatient}} '''OR'''
	*{{AntibioticDose\|disease=Pyelonephritis\|drug=Imipenem/Cilastatin\|dose=500mg IV q8hr\|context=Adult Inpatient}}		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Imipenem/Cilastatin\|dose=500mg IV q8hr\|context=Adult Inpatient}}


			====Pediatric Outpatient Options====
			*{{AntibioticDose\|disease=Pyelonephritis\|drug=Cephalexin\|dose=25-50mg/kg/day PO divided q6-8h x 10-14 days (max 500mg/dose)\|context=Pediatric Outpatient\|population=Pediatric}} '''OR'''
			*{{AntibioticDose\|disease=Pyelonephritis\|drug=Cefixime\|dose=8mg/kg PO daily x 10-14 days (max 400mg)\|context=Pediatric Outpatient\|population=Pediatric}} '''OR'''
			*{{AntibioticDose\|disease=Pyelonephritis\|drug=Cefdinir\|dose=14mg/kg/day PO divided BID x 10 days (max 600mg/day)\|context=Pediatric Outpatient\|population=Pediatric}} '''OR'''
			*{{AntibioticDose\|disease=Pyelonephritis\|drug=Cefpodoxime\|dose=10mg/kg/day PO divided BID x 10 days (max 200mg/dose)\|context=Pediatric Outpatient\|population=Pediatric}} '''OR'''
			*{{AntibioticDose\|disease=Pyelonephritis\|drug=Trimethoprim-Sulfamethoxazole DS\|display=TMP/SMX\|dose=6-12mg/kg/day (TMP) PO divided BID x 10-14 days\|context=Pediatric Outpatient\|population=Pediatric}}
	====Pediatric Inpatient Options====		====Pediatric Inpatient Options====
	*{{AntibioticDose\|disease=Pyelonephritis\|drug=Ceftriaxone\|dose=75mg/kg IV QD\|context=Pediatric Inpatient\|population=Pediatric}} '''OR'''		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Ceftriaxone\|dose=75mg/kg IV QD\|context=Pediatric Inpatient\|population=Pediatric}} '''OR'''

← Revisión anterior		Revisión del 10:54 20 mar 2026
Línea 21:		Línea 21:
	*{{AntibioticDose\|disease=Pyelonephritis\|drug=Cefotaxime\|dose=50mg/kg IV q8hrs\|context=Pediatric Inpatient\|population=Pediatric}} '''OR'''		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Cefotaxime\|dose=50mg/kg IV q8hrs\|context=Pediatric Inpatient\|population=Pediatric}} '''OR'''
	*{{AntibioticDose\|disease=Pyelonephritis\|drug=Ampicillin\|dose=25mg/kg IV q6hrs\|context=Pediatric Inpatient\|population=Pediatric}} '''+''' {{AntibioticDose\|disease=Pyelonephritis\|drug=Gentamicin\|dose=2.5mg/kg IV q8hrs\|context=Pediatric Inpatient\|population=Pediatric\|link=no}}		*{{AntibioticDose\|disease=Pyelonephritis\|drug=Ampicillin\|dose=25mg/kg IV q6hrs\|context=Pediatric Inpatient\|population=Pediatric}} '''+''' {{AntibioticDose\|disease=Pyelonephritis\|drug=Gentamicin\|dose=2.5mg/kg IV q8hrs\|context=Pediatric Inpatient\|population=Pediatric\|link=no}}
			*{{AntibioticDose\|drug=Ampicillin/Sulbactam\|dose=3g IM/IV q6 hours x 14 days\|context=UTI, Pyelonephritis\|disease=Pyelonephritis\|population=Adult}}